Table 2. Anthropometric data of patients.
| Obese FS patients (n=42) | Overweight FS patients (n=27) | Normoweight FS patients (n=32) | ||||||||
| n | % | Mean±SD | n | % | Mean±SD | n | % | Mean±SD | p | |
| Waist circumference (cm) | 124.1±10.1 | 90.7±7.5 | 78.6±6.8 | <0.001 | ||||||
| No risk (<80) | - | - | 2 | 7,4 | 18 | 56,3 | ||||
| Medium risk (80-87) | 1 | - | 8 | 29,6 | 12 | 37,5 | <0.001* | |||
| High risk (>88) | 41 | - | 17 | 63 | 2 | 6,3 | ||||
| Hip circumference (cm) | 126.6±8.1 | 100.0±5.0 | 99.2±6.2 | <0.001†,‡ | ||||||
| Waist/Hip Ratio | 0.9±0.1 | 0.9±0.09 | 0.7±0.1 | <0.001 | ||||||
| No risk (<0.80) | - | - | 2 | 18 | ||||||
| Medium risk (0.81-0.85) | 4 | - | 6 | 10 | <0.001* | |||||
| High risk (>0.85) | 41 | - | 19 | 4 | ||||||
| Fat free mass | 50.7±7.9 | 46.2±3.0 | 46.6±2.5 | 0.005† | ||||||
| Fat mass | 46.5±8.9 | 27.8±1.4 | 23.1±1.9 | <0.001 | ||||||
| Body fat percentage | 49.1±2.8 | 35.3±1.2 | 30.8±1.3 | <0.001 | ||||||
| FS: Fibromyalgia syndrome; SD: Standard deviation; * Chi-square test; † Group obese-overweight; ‡ Group obese-normoweight; c: Group overweight-normoweight. | ||||||||||